Dementia with Lewy bodies

Annales de Medecine Interne

Volumn 149, Issue 4, 1998, Pages 209-215

  Verny, Marc ^a,b   Duyckaerts, Charles ^b  

^a HÔPITAL CHARLES FOIX   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Alzheimer disease; Parkinson's disease; Parkinsonism; Visual hallucinations

Indexed keywords

ANTIBODY; UBIQUITIN;

AGED; ALZHEIMER DISEASE; COGNITIVE DEFECT; CONSCIOUSNESS DISORDER; DELIRIUM; DISEASE ASSOCIATION; FALLING; HUMAN; LEWY BODY; NEUROPATHOLOGY; PARKINSON DISEASE; PARKINSONISM; REVIEW; SENILE PLAQUE; SUBSTANTIA NIGRA; SYNCOPE; VISUAL HALLUCINATION;

AGED; ALZHEIMER DISEASE; CEREBRAL CORTEX; DIAGNOSIS, DIFFERENTIAL; HUMANS; LEWY BODIES; LEWY BODY DISEASE; NEUROLOGIC EXAMINATION; NEUROPSYCHOLOGICAL TESTS;

EID: 0031877317     PISSN: 0003410X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (63)

1. OKAZAKI H, LIPKIN LE, ARONSON SM: Diffuse intracytoplasmic inclusions (Lewy type) associated with progressive dementia and quadriparesis in flexion. J Neuropathol Exp Neurol 1961; 20: 237-44.
2. YOSHIMURA M: Cortical changes in the parkinsonian brain: a contribution to the delineation of "diffuse Lewy body disease". J Neurol 1983; 229; 17-32.
3. GIBB WR, LUTHERT PJ, JANOTA I, LANTOS PL: Cortical Lewy body dementia: clinical features and classification. J Neurol Neurosurg Psychiatry 1989; 52: 185-92.
4. PERRY RH, IRVING D, BLESSED G, FAIRBAIRN A, PERRY EK: Senile dementia of Lewy body type. A clinically and neuropathologically distinct form of Lewy body dementia in elderly. J Neurol Sci 1990; 95: 119-39.
5. HANSEN L, SALMON D, GALASKO D, et al.: The Lewy body variant of Alzheimer's disease: a clinical and pathologic entity. Neurology 1990; 40: 1-8.
6. DE LA MONTE SM, WELLS SE, HEDLEY-WHYTE ET, GROWDON JH: Neuropathological distinction between Parkinson's dementia and Parkinson's plus Alzheimer's disease. Ann Neurol 1989; 26: 309-20.
7. KOSAKA K, YOSHIMURA M, IKEDA K, BUDKA H: Diffuse type of Lewy body disease: progressive dementia with abundant cortical Lewy bodies and senile changes of varying degree: a new disease? Clin Neuropathol 1984; 3: 185-92.
8. KOSAKA K: Diffuse Lewy body disease in Japan. J Neurol 1990; 237: 197-204.
9. MCKEITH IG, GALASKO D, KOSAKA K, et al.: Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 1996; 47: 1113-24.
10. KALRA S, BERGERON C, LANG AE: Lewy body disease and dementia. A review. Arch Intern Med 1996; 156: 487-93.
11. LEWY FH: Paralysis agitans. I-Pathologische anatomie. In: M L, eds. Handbuch der Neurologie. Berlin: Springer 1912: 920-33.
12. TRETIAKOFK C: Contribution à l'étude de l'anatomie pathologique du locus niger de Soemmering avec quelques déductions relatives à la pathogénie des troubles du tonus musculaire et de la maladie de Parkinson (thesis). Paris, 1919.
13. LENNOX G, LOWE J, MORRELL K, LANDON M, MAYER RJ: Anti-ubiquitin immunocytochemistry is more sensitive than conventional techniques in the detection of diffuse Lewy body disease. J Neurol Neurosurg Psychial 1989; 52: 67-71.
14. SPILLANTINI MG, SCHMIDT ML, LEE VMY, TROJANOWSKI JQ, JAKES R, GOEDERT M: Alpha-synuclein in Lewy bodies. Nature 1997; 388: 839-40.
15. BANCHER C, JELLINGER KA, EDER H: Selective visualisation of cortical Lewy bodies by immunoimmunocytochemical double-labelling: an aid in the diagnosis of combined pathologies.
16. FORNO LS: Neuropathology of Parkinson's disease. J Neuropathol Exp Neurol 1996; 55: 259-72.
17. HUGHES AJ, DANIEL SE, BLANKSON S, LEES AJ: A clinicopathologic study of 100 cases of Parkinson's disease. Arch Neurol 1993; 50: 140-8.
18. SAMUEL W, GALASKO D, MASLIAH E, HANSEN LA: Neocortical Lewy body counts correlate with dementia in the Lewy body variant of Alzheimer's disease. J Neuropathol Exp Neurol 1996; 55: 44-52.
19. SAMUEL W, ALFORD M, HOFSTETTER CR, HANSEN L: Dementia with Lewy bodies versus pure Alzheimer disease: differences in cognition, neuropathology, cholinergic dysfunction, and synapse density. J Neuropathol Exp Neurol 1997; 56: 499-508.
20. REZAIE P, CAIRNS NJ, CHADWICK A, LANTOS PL: Lewy bodies are located preferentially in limbic areas in diffuse Lewy body disease. Neurosc Lett 1996; 212: 111-4.
21. BURKHARDT CR, FILLEY CM, KLEINSCHMIDT-DEMASTER BK, DE LA MONTE S, NORENBERG MD, SCHNECK SA: Diffuse Lewy body disease and progressive dementia. Neurology 1988; 38: 1520-8.
22. LOUIS ED, KLATKA DO, LIU Y, FAHN S: Comparison of extrapyramidal features in 31 pathologically confirmed cases of diffuse Lewy body disease and 34 pathologically confirmed cases of Parkinson's disease. Neurology 1997; 48: 376-80.
23. AMERICAN PSYCHIATRIC ASSOCIATION: Diagnostic and statistical manual of mental disorders IV. Washington DC: 1994.
24. GALASKO D, KATZMAN R, SALMON DP, HANSEN L: Clinical and neuropathological findings in Lewy body dementias. Brain Cog 1996; 31: 166-75.
25. SHAGAL A, GALLOWAY PH, MCKEITH IG, EDWARDSON JA, LLOYD S: A comparative study of attentional deficits in senile dementia of Alzheimer and Lewy body types. Dementia 1992; 3: 350-4.
26. SALMON DP, GALASKO D: Neuropsychological aspects of Lewy body dementia. In: Perry RH, McKeith IG, Perry EK, eds. Dementia with Lewy bodies. New York: Cambridge University Press: 1996; 99-113.
27. GNANALINGHAM KK, BYRNE EJ, THORNTON A, SAMBROOK MA, BANNISTER P: Motor and cognitive function in Lewy body dementia: a comparison with Alzheimer's and Parkinson's diseases. J Neurol Neurosurg Psychiatry, 1997; 62: 243-52.
28. BYRNE EJ, LENNOX G, GODWIN-AUSTEN RB, et al.: Dementia associated with cortical Lewy bodies: proposed clinical diagnostic criteria. Dementia 1991; 2: 283-4.
29. KLATKA LA, LOUIS ED, SCHIFFER RB: Psychiatric features in diffuse Lewy body disease: A clinicopathologic study using Alzheimer's disease and Parkinson's disease comparison groups. Neurology 1996; 47: 1148-52.
30. MCKKITH IG, PERRY RH, FAIRBAIRN AF, JABEEN S, PERRY EK: Operational criteria for senile dementia of Lewy body type (SDLT). Psych Med 1992; 22: 911-22.
31. BALLARD C, HARRISON RWS, LOWERY K, MCKEITH IG: Non-cognitive symptoms in Lewy body dementia. In: Perry RH, McKeith IG, Perry EK, eds. Dementia with Lewy bodies. New York: Cambridge University Press: 1996; 67-84.
32. MCSHANE R, GEDLING K, READING M, MCDONALD B, ESIRI MM, HOPE T: Prospective study of the relations between cortical Lewy bodies, poor eyesight, and hallucinations in Alzheimer's disease. J Neurol Neurusurg Psychiat 1995; 59: 185-8.
33. PERRY EP, IRVING D, KERWIN JM et al.: Cholinergic transmitter and neurotrophic activities in Lewy body dementia: similarity to Parkinson's and distinction from Alzheimer disease. Alz Dis Assoc Disorders 1993; 7: 69-79.
34. MCKEITH I, FAIBURN A, PERRY R, THOMPSON P, PERRY E: Neuroleptic sensitivity in patients with senile dementia of the Lewy body type. B Med J 1992; 305: 673-8.
35. LENNOX G: Lewy body dementia. In: ROSSOR MN, eds. Unusual dementias. London: Baillière Tindall: 1992; 653-76.
36. BYRNE EJ, LENNOX G, LOWE J, GODWIN-AUSTEN RB: Diffuse Lewy body disease: clinical features in 15 cases. J Neurol Neurosurg Psychiatry 1989; 52: 709-17.
37. CRYSTAL HA, DICKSON DW, LIZARDI JE, DAVIES P, WOLFSON LI: Antemortem diagnosis of diffuse Lewy body disease. Neurology 1990; 40: 1523-8.
38. FORSTI H, BURNS A, LUTHERT P, CAIRNS N, LEVY R: The Lewy-body variant of Alzheimer's disease: clinical and pathological findings. Br J Psychiatry 1993; 162: 385-92.
39. LITVAN I, MACINTYRE A, GOETZ C, et al.: Accuracy of the clinical diagnosis of Parkinson's disease and dementia with Lewy bodies: A clinicopathologic study. Arch Neurol 1998 (in press).
40. BOLLER F, MIZUTANI R, ROESSMANN U, GAMBETTI P: Parkinson's disease, dementia and Alzheimer's disease: clinico-pathological correlations. Ann Neurol 1980; 1: 329-55.
41. TERRY RD, HANSEN LA, DE TRESA R, DAVIES P, TOBIAS H, KATZMAN R: Senile dementia of the Alzheimer type without neocortical neurofibrillary tangles. J Neuropathol Exp Neurol 1987; 46: 262-8.
42. HANSEN LA, MASLIAH E, GALASKO D, TERRY RD: Plaque only Alzheimer disease is usually the Lewy body variant and vice versa. J Neuropathol Exp Ncurol 1993; 52: 648-54.
43. DICKSON DW, SCHMIDT ML, LEE VMY, ZHAO ML, YEN SH, TROJANOWSKI JQ: Immunoreactive profile of hippocampal Ca2/3 neurites in diffuse Lewy body disease. Acta Neuropathol (Berl) 1994; 87; 269-76.
44. BRAAK H, BRAAK E, YILMAZER D, SCHULTZ C, DEVOS RAI, JANSEN ENH: Nigral and extranigral pathology in Parkinson's disease. J Neural Transm 1995; Suppl 46: 15-31.
45. GAI WP, BLESSING WS, BLUMBERGER PC: Ubiquitin-positive degenerating neurites in the brainstem in Parkinson's disease. Brain 1995; 118: 1447-60.
46. KIM H, GEARING M, MIRRA SS: Ubiquitin positive CA2/3 neurites in hippocampus coexist with cortical Lewy bodies. Neurology 1995; 45: 1765-70.
47. BRAAK H, BRAAK E, YILMAZER D et al.: Amygdala pathology in Parkinson's disease. Acta Neuropathol (Berl) 1994; 87: 493-500.
48. SCHMIDT ML, MARTIN JA, LEE VMY, TROJANOWSKI JQ: Convergence of Lewy bodies and neurofibrillary tangles in amygdala neurons of Alzheimer's disease and Lewy body disorders. Acta Neuropathol (Berl) 1996; 91: 475-81.
49. HANSEN LA, MASLIAH E, TERRY RD, MIRRA SS: A neuropathological subset of Alzheimer's disease with concomitant Lewy body disease and spongiform change. Acta Neuropathol (Berl) 1989; 78: 194-201.
50. DUYCKAERTS C, GASPAR P, COSTA C, BONNET AM, HAUW JJ: Dementia in Parkinson's disease. Adv Neurol 1993; 60: 447-55.
51. GASPAR P, GRAY F: Dementia in idiopathic Parkinson disease. A neuropathological study of 32 cases. Acta Neuropathol (Berl) 1984; 64: 43-52.
52. ARMSTRONG M, DALY AK, CHOLERTON S, BATEMAN DN, IDLE JR: Mutant debrisoquine hydroxylation genes in Parkinson's disease. Lancet 1992; 339: 1017-18.
53. GASSER T, MULLER-MYHSOK B, SUPALA A et al.: The CYP2D6B allele is not overrepresented in a population of German patients with idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry 1996; 61: 518-20.
54. SAITOH T, XIA Y, CHEN X et al.: The CYP2D6B mutant allele is overrepresented in the Lewy body variant of Alzheimer's disease. Ann Neurol 1995; 37: 110-2.
55. LANTOS PL, OVENSTONE IM, JOHNSON J, CLELLAND CA, ROQUES P, ROSSOR MN: Lewy bodies in the brain of two members of a family with the 717 (Val to Ile) mutation of the amyloid precursor protein gene. Neurosci Lett 1994; 179: 77-9.
56. LIPPA CF, SMITH TW, NEE L, et al.: Familial Alzheimer's disease and cortical Lewy bodies: is there a genetic susceptibility factor? Dementia 1995; 6: 191-4.
57. ISHIKAWA A, TAKAHASHI H, TANAKA H, HAYASHI T, TSUJI S: Clinical features of familial diffuse Lewy body disease. Eur Neurol 1997; 38 (suppl 1), 34-8.
58. POLYMEROPOULOS MH, LAVEDAN C, LEROY E et al.: Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science 1997; 276: 2045-7.
59. IWAI A, MASLIAH E, YOSHIMOTO M, et al.: The precursor protein of non-A beta component of Alzheimer's disease amyloid is a presynaptic protein of the central nervous system. Neuron 1995; 14: 467-75.
60. CHACKO RC, HURLEY RA, JANKOVIC J: Clozapine use in diffuse Lewy body disease. J Neuropsychiatry Clin Neurosci 1993; 5: 206-8.
61. PERRY EP, IRVING D, KERWIN JM et al.: Cholinergic transmitter and neurotrophic activities in Lewy body dementia: similarity to Parkinson's and distinction from Alzheimer's disease. Alz Dis Assoc Disorders 1993; 7: 69-79.
62. PERRY EP, HAROUTUNIAN V, DAVIS KL, et al.: Neocortical cholinergic activities differentiate Lewy body dementia from classical Alzheimer's disease. NeuroReport 1994; 5: 747-9.
63. WILCOCK GK, SCOTT M: Tacrine for senile dementia Alzheimer's type or Lewy body type. Lancet 1994; 344: 544.